Epithelial Cell Adhesion Molecule in Primary Sjögren’s Syndrome Patients: Characterization and Evaluation of a Potential Biomarker

Abstract EN

Objective.

To determine the subcellular localization of epithelial cell adhesion molecule (EpCAM) in labial salivary gland (LSG) and evaluate the diagnostic use of the extracellular domain of EpCAM (EpEX) and intracellular domain (EpICD) for primary Sjögren’s syndrome (pSS).

Methods.

Immunohistochemical (IHC) analysis was conducted using EpEX and EpICD domain-specific antibodies on labial salivary gland biopsy (LSGB) from participants.

Chi-square or Fisher’s exact analysis, Mann–Whitney U-test, and Kruskal-Wallis test compared differences among groups.

Independent risk factors of pSS were determined by multiple logistic regression analysis.

Receiver-operator characteristic curves (ROC) were carried out to estimate the diagnostic value.

Results.

Compared to non-SS controls, loss of membranous EpEX and EpICD expression was observed in LSGB of pSS patients, which occurred in parallel with increased accumulation of cytoplastic and nuclear EpICD.

The subcellular EpEX/EpICD expressions were associated with various features of pSS patients, especially histopathological grade of LSGB.

Furthermore, high IHC scores of membranous EpEX were independent risk factors for pSS, even for the pSS patients at early stage.

The IHC scores of subcellular EpEX/EpICD were of great diagnostic value for pSS with high sensitivity (70-80%) and specificity (85-95%).

Conclusion.

This study first found the aberrant expression pattern of EpCAM in LSG of pSS patients.

The IHC scores of subcellular EpEX/EpICD were demonstrated to have the potential to act as diagnostic biomarkers for pSS.